Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment
NCT06262009 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 525
Last updated 2026-04-23
Summary
Humans in contact with animals such as dog owners, may be at risk of antimicrobial resistance (AMR) acquisition. This is the central issue to be investigated in DYASPEO
Conditions
- Antibiotic Resistant Strain
- Transmission, Close-Contact
Interventions
- OTHER
-
human faecal collection
collecting stools 6 times over a 90 days period and complete a questionnaire at the same times: D1, D7, D15, D30, D60 and D90
- OTHER
-
ancillary study
interviews and/or ethnographic observations for 50 volunteers
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Jean-Yves Madec, PHD · ANSES
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-12-15
- Primary Completion
- 2028-09-30
- Completion
- 2029-03-31
Countries
- France
Study Locations
More Related Trials
-
A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.
NCT07234331 ·Status: RECRUITING
-
Carriage Of Multiresistant Bacteria After Travel
NCT01676974 ·Status: COMPLETED
-
Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management
NCT05200546 ·Status: COMPLETED
-
Amplification and Selection of Antimicrobial Resistance in the Intestine II
NCT03140826 ·Status: COMPLETED
-
Existence in the Human Digestive Flora of Phages Able to Prevent the Acquisition of Multiresistant Enterobacteria
NCT03231267 ·Status: UNKNOWN
-
Prevention of Carbapenemase-producing Enterobacteriaceae Epidemics: Evaluation of a Simplified Contact Screening Policy (CADECO)
NCT06839911 ·Status: ACTIVE_NOT_RECRUITING
-
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
NCT05791396 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Epidemiology of Resistant Microbial Strains Among Different Groups of People (Healthy, Infected and Exposed to Animals)
NCT03343119 ·Status: UNKNOWN
-
Effect of Antibiotics on Gut Microbiome and Plasma Metabolome
NCT03273296 ·Status: COMPLETED ·Phase: PHASE4
-
Cohort Study of German Hematological / Oncological Wards to Assess the Effect of Contact Precautions on Nosocomial Colonization With Vancomycin Resistant Enterococci
NCT02623413 ·Status: UNKNOWN
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
NCT02852902 ·Status: COMPLETED
-
Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island
NCT03226314 ·Status: UNKNOWN
-
Multi-Antibiotic Resistance Carriage in Gut Flora
NCT01591538 ·Status: COMPLETED
-
Implications of the Human Microbiota for Health and Disease
NCT04203303 ·Status: RECRUITING
-
Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
NCT06258551 ·Status: RECRUITING
-
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
NCT03250104 ·Status: COMPLETED
-
Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
NCT03477084 ·Status: COMPLETED
-
Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection
NCT04131569 ·Status: UNKNOWN
-
Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
NCT02127450 ·Status: COMPLETED
-
Phages Dynamics and Influences During Human Gut Microbiome Establishment
NCT03296631 ·Status: TERMINATED
-
Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM
NCT05285046 ·Status: UNKNOWN
-
Feasibility Studies to Inform Novel Proposals to Avert Community-Based Antimicrobial Resistance Spread
NCT02666274 ·Status: UNKNOWN
-
Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes.
NCT03248999 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares
NCT00976638 ·Status: COMPLETED ·Phase: NA
-
Multi-resistant Enterobacteriaceae Colonisation in Less Than 32 Weeks Pregnant Women Admitted to the Hospital.
NCT02631226 ·Status: UNKNOWN